Establishment of the Therapeutic Antibody Core
The Therapeutic Antibody Core was launched in 2015 with a 5-year grant from the Cancer Prevention & Research Institute of Texas (CPRIT). This work was built on the foundation of a translational research program for antibody drug discovery built by Director and Co-Director Zhiqiang An and Ningyan Zhang. Their facility, the Texas Therapeutics Institute, is part of the Brown Foundation Institute of Molecular Medicine in the McGovern Medical School in the University of Texas Health Science Center at Houston.
The expertise of the team is previously well recognized. They are also recipients of another CPRIT grant investigating how tumors evade therapeutic antibodies.